A detailed history of Ikarian Capital, LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 274,551 shares of AMLX stock, worth $1.36 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
274,551
Previous 331,451 17.17%
Holding current value
$1.36 Million
Previous $941,000 44.63%
% of portfolio
0.21%
Previous 0.12%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.62 - $2.71 $92,178 - $154,199
-56,900 Reduced 17.17%
274,551 $521,000
Q1 2024

May 15, 2024

SELL
$2.71 - $19.57 $1.48 Million - $10.7 Million
-546,049 Reduced 62.23%
331,451 $941,000
Q4 2023

Feb 14, 2024

BUY
$12.07 - $18.46 $10.6 Million - $16.2 Million
877,500 New
877,500 $12.9 Million
Q1 2023

May 15, 2023

BUY
$27.71 - $40.93 $277,100 - $409,300
10,000 New
10,000 $293,000
Q2 2022

Aug 12, 2022

SELL
$6.85 - $19.93 $1.03 Million - $2.99 Million
-150,100 Reduced 37.84%
246,554 $4.75 Million
Q1 2022

May 13, 2022

BUY
$12.85 - $32.9 $5.1 Million - $13 Million
396,654 New
396,654 $5.1 Million

Others Institutions Holding AMLX

About Amylyx Pharmaceuticals, Inc.


  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $290M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.